From: Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's disease
Compounds
MW
HBA
HBD
MlogP
Lipinski violations
NRB
TPSA
WLogP
13
426.94
3
1
3.35
0
6
59.27
2.64
21
382.89
2
61.02
3.33